Warren Joubert Selected Research

Antibodies

1/2016

ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Warren Joubert Research Topics

Disease

2	Neoplasms (Cancer) 12/2020 - 01/2019
1	Thrombosis (Thrombus) 12/2020
1	Dehydration (Water Stress) 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Proteinuria 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Vomiting 01/2019
1	Alveolar Soft Part Sarcoma 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016

Drug/Important Bio-Agent (IBA)

1	cediranib (AZD2171)IBA 01/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2016
1	Monoclonal AntibodiesIBA 01/2016
1	Cetuximab (Erbitux)FDA Link 01/2016
1	AntibodiesIBA 01/2016

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2019 - 01/2016
2	Radiotherapy 01/2019 - 01/2016
1	Catheters 12/2020
1	Metastasectomy 01/2016